Publications
148
Citations
4,694
Est. group size
—
Recurring co-author estimate
Active years
13
Publishing since 2014
Narasimha M. Beeraka works in biomedical research focused on cancer biology and drug discovery, designing and testing new chemical compounds (such as pyrimidine and oxadiazole derivatives) that target signaling pathways in breast cancer and other cancers. The work also spans reviews of disease mechanisms in neurological disorders, metabolic and liver disease, and global disease burden studies. Much of the research combines synthetic chemistry, computational (in silico) screening, and laboratory (in vitro) cell studies.
Publication activity grew rapidly from 2019, peaked around 2022, and has remained high and fairly steady since (roughly 20+ papers per year).
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Global burden of metabolic dysfunction-associated steatotic liver disease, 1990–2023, and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2023
The Lancet. Gastroenterology & hepatology · 2026
- Targeting c-Met and EMT, PI3K/Akt/mTOR/MEK signaling with Dihydropyrimidinone-Piperazine-based scaffold that triggers apoptosis, autophagy, and paraptosis in breast carcinomas
Biomedicine & Pharmacotherapy · 2026
- Recent Updates on Lipid Landscapes in Neonatal and Adult Neurological Disorders: Advancing Mass Spectrometry and Lipidomics for Disease Insight: A Systematic Review
CNS & Neurological Disorders - Drug Targets · 2026
- Nano-TiO <sub>2</sub> Catalyst-Based Method Development to Synthesize Pyrano-Chromenes Targeting TFF3 in Breast Cancer
Polycyclic aromatic compounds · 2026
- Pyrimidine-Piperazine Hybrids as Potential PARP1 Inhibitors: Dual in silico and in vitro Approaches against Breast Cancer
Asian Journal of Chemistry · 2026
- Dual action of pyrimidine derivatives: Targeting tamoxifen resistance in breast cancer
Translational Oncology · 2025
- Global burden and trends of breast cancer: GLOBOCAN 2022 estimates of incidence and mortality in 185 countries
Chinese Medical Journal · 2025
- Targeting breast cancer cells with 2-indolyl-1,3,4-oxadiazole compounds by inducing apoptosis, paraptosis and autophagy
Chemico-Biological Interactions · 2025
- Exploring the Role of Lower Genital Tract Microbiota and Cervical–Endometrial Immune Metabolome in Unknown Genesis of Recurrent Pregnancy Loss
International Journal of Molecular Sciences · 2025
- Ginsenoside Rh4 Suppresses Notch3 and PI3K/Akt Pathway to Inhibit Growth and Metastasis of Gastric Cancer Cells
Journal of Cancer Biomoleculars and Therapeutics · 2025
- Updates on Intrinsic Medicinal Chemistry of 1,4-dihydropyridines, Perspectives on Synthesis and Pharmacokinetics of Novel 1,4-dihydropyrimidines as Calcium Channel Blockers: Clinical Pharmacology
Current Topics in Medicinal Chemistry · 2025
- Targeting the epigenome and tumor heterogeneity: advances in immunotherapy for chemoresistant metastatic colorectal cancer
Frontiers in Immunology · 2025
- From inflammation to intervention: exploring shared mechanisms and lifestyle strategies in diabetes mellitus and multiple sclerosis
International Immunopharmacology · 2025
- Exploring Hypoxia-Induced Neuroprotection Mechanisms in Post-Stroke Recovery
Translational Stroke Research · 2025
- Development of novel pyrimidine-thio-triazoles targeting EGFR in breast Cancer cells via one-pot copper-catalyzed 1,3-dipolar cycloaddition
Results in Chemistry · 2025
- Current Medicinal Chemistry×14
- Current Pharmaceutical Design×9
- International Journal of Molecular Sciences×5
- Research Square×5
- Molecular Neurobiology×4
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile